|
N/A
|
ACN12001-001
|
$270
|
-, -
|
NASA/JPL JET PROPULSION LABORA
|
|
(6) Molecular mechanisms explaining premalignant changes in the etiology of melanoma
|
5R21CA208736-02
|
$180,000
|
MURPH, MANDI
|
UNIVERSITY OF GEORGIA
|
|
(PQ #10) Gut-brain interactions underlying chemotherapy-induced behavioral comorbidities
|
5R01CA216290-02
|
$309,819
|
PYTER, LEAH
|
OHIO STATE UNIVERSITY
|
|
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis
|
5R21CA216304-02
|
$195,750
|
NEWMEYER, DONALD
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy
|
5R21CA215985-02
|
$165,000
|
CHANG, KAREN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
5R01CA216054-02
|
$324,411
|
HAYDEN GEPHART, MELANIE
|
STANFORD UNIVERSITY
|
|
(PQ3) Immune Modulation of DNA Mismatch Repair in Colorectal Cancer
|
5R01CA206010-03
|
$369,639
|
CARETHERS, JOHN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
|
5R01CA216242-02
|
$319,238
|
MACLEOD, KAY
|
UNIVERSITY OF CHICAGO
|
|
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity
|
5R01CA205967-03
|
$386,588
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INST
|
|
(PQ5) Role of Mitochondrial Division in Cancer Biology
|
5R01CA206005-03
|
$351,209
|
CHIPUK, JERRY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
|
5R01CA205632-03
|
$457,974
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
|
5R01CA206028-03
|
$342,846
|
GEWIRTZ, DAVID
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
5R01CA205255-03
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
(PQA5) Dose and Mechanisms of Exercise in Breast Cancer Prevention
|
5R01CA179992-05
|
$648,503
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
00005I-0140 NCI-OD -- 8422873
|
271201800005I
|
$43,698
|
N/A
|
KELLY SERVICES INC
|
|
00007I-4739 NCI-OD -- 8422873
|
271201500007I
|
$24,553
|
N/A
|
KELLY SERVICES INC
|
|
00012I-0329 NCI-OD -- 8422873
|
271201800012I
|
$137,572
|
N/A
|
KELLY SERVICES INC
|
|
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048377-25
|
$39,000
|
GADDE, KISHORE
|
LSU PENNINGTON BIOMEDICAL RESEARCH CTR
|
|
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048381-25
|
$68,181
|
EHRMANN, DAVID
|
UNIVERSITY OF CHICAGO
|
|
03/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048468-25
|
$68,181
|
FURLONG, KEVIN
|
THOMAS JEFFERSON UNIVERSITY
|
|
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048434-25
|
$68,181
|
GOLDBERG, RONALD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
05/22 Diabetes Prevention Program Outcomes Study (DPPOS) - Phase 3 - Research Project
|
5U01DK048514-25
|
$68,181
|
HAZUDA, HELEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048375-25
|
$68,181
|
DABELEA, DANA
|
UNIVERSITY OF COLORADO DENVER
|
|
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project
|
5U01DK048437-25
|
$42,300
|
MUNSHI, MEDHA
|
JOSLIN DIABETES CENTER
|
|
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048413-25
|
$68,181
|
KAHN, STEVEN
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
|
09/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048411-25
|
$58,181
|
DAGOGO-JACK, SAMUEL
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3- Research Project
|
5U01DK048380-25
|
$68,181
|
MOLITCH, MARK
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048397-25
|
$68,181
|
NATHAN, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
13/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048404-25
|
$68,181
|
PI-SUNYER, XAVIER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
14/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048406-25
|
$68,181
|
MATHER, KIEREN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
|
5R01CA206539-03
|
$366,000
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
15-PGDH in Cholangiocarcinogenesis
|
5R01CA102325-12
|
$344,269
|
WU, TONG
|
TULANE UNIVERSITY OF LOUISIANA
|
|
15/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048387-25
|
$68,181
|
MAGEE, MICHELLE
|
MEDSTAR HEALTH RESEARCH INSTITUTE
|
|
16/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048443-25
|
$68,181
|
WATSON, KAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
17/22 DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS) PHASE 3 - RESEARCH PROJECT
|
5U01DK048400-25
|
$22,085
|
BROWN, ANGELA
|
WASHINGTON UNIVERSITY
|
|
18/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Project
|
5U01DK048485-25
|
$68,181
|
GOLDEN, SHERITA
|
JOHNS HOPKINS UNIVERSITY
|
|
19/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048407-25
|
$44,000
|
SCHADE, DAVID
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048349-26
|
$68,181
|
CRANDALL, JILL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
2015 Radiation Epidemiology Course
|
ZIA CP010131 10596
|
$30,751
|
Berrington, Amy
|
DCEG (NCI)
|
|
2018 SEER ADVANCED TOPICS FOR REGISTRY PROFESSIONALS WORKSHOP
|
261201800246P
|
$25,000
|
ALLEN, NANCY
|
NATIONAL CANCER REGISTRAR'S ASSOCIATION
|
|
21/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048412-25
|
$68,181
|
VENDITTI, ELIZABETH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center
|
5U01DK048489-25
|
$203,538
|
TEMPROSA, MARINELLA
|
GEORGE WASHINGTON UNIVERSITY
|
|
2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization
|
5R01CA194307-03
|
$105,860
|
EISENBREY, JOHN
|
THOMAS JEFFERSON UNIVERSITY
|
|
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma
|
5R01CA203388-02
|
$413,689
|
MAO, HUI
|
EMORY UNIVERSITY
|
|
3-D modeling-based decision support for optimizing quality of life following breast reconstruction
|
5R01CA203984-03
|
$669,662
|
MARKEY, MIA
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
3D Dynamic Contrast-Enhanced US for Monitoring Chemotherapy of Liver Metastasis
|
5R01CA195443-03
|
$208,861
|
KAMAYA, AYA
|
STANFORD UNIVERSITY
|
|
3D Prostate Histochemometry to Predict Disease Recurrence
|
5R01CA197516-03
|
$400,610
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
|
5R01CA174929-05
|
$570,235
|
PARK, CATHERINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Case-Control Study of Lung Cancer among Non-smoking Women in Xuan Wei and Fu
|
ZIA CP010121 10349
|
$53,686
|
Lan, Qing
|
DCEG (NCI)
|
|
A Chemopreventive Strategy Based on Edible MicroRNAs Produced in Plants
|
1R21CA223353-01
|
$156,514
|
VANCE, VICKI
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|